Increased vascular contractility and oxidative stress in β 2-adrenoceptor knockout mice: The role of NADPH oxidase

Journal of Vascular Research

Volumn 49, Issue 4, 2012, Pages 342-352

  Davel, A P ^a,b   Ceravolo, G S ^b   Wenceslau, C F ^b   Carvalho, M H C ^b   Brum, P C ^b   Rossoni, L V ^b  

^a UNIVERSITY OF CAMPINAS   (Brazil)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

2 adrenoceptor; Aorta; Endothelium; Nitric oxide; Oxidative stress; Vascular reactivity

Indexed keywords

APOCYNIN; BETA 2 ADRENERGIC RECEPTOR; ENDOTHELIAL NITRIC OXIDE SYNTHASE; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; PHENYLEPHRINE; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; SUPEROXIDE; SUPEROXIDE DISMUTASE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; AORTA; BLOOD PRESSURE; CONTROLLED STUDY; GENE SILENCING; MALE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; REVIEW; VASOCONSTRICTION; WESTERN BLOTTING;

ACETOPHENONES; ANIMALS; AORTA, THORACIC; ENDOTHELIUM, VASCULAR; MALE; MICE; MICE, KNOCKOUT; NADPH OXIDASE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE III; OXIDATIVE STRESS; PHENYLEPHRINE; RECEPTORS, ADRENERGIC, BETA-2; SUPEROXIDES; VASOCONSTRICTION;

EID: 84861330256     PISSN: 10181172     EISSN: 14230135     Source Type: Journal    
DOI: 10.1159/000337486     Document Type: Review

References (43)

1. Tanaka Y, Horinouchi T, Koike K: New insights into adrenoceptors in smooth muscle: distribution of receptor subtypes and molecular mechanisms triggering muscle relaxation. Clin Exp Pharmacol Physiol 2005; 32: 503-514. (Pubitemid 41021061)
2. Steinberg SF, Jaffe EA, Bilezikian JP: Endothelial cells contain adrenoceptors. Naunyn-Schmiedebergs Arch Pharmacol 1984; 325: 310-313.
3. Molenaar P, Malta E, Jones CR, Buxton BF, Summers RJ: Autoradiographic localization and function of adrenoceptors on the human internal mammary artery and saphenous vein. Br J Pharmacol 1988; 95: 225-233.
4. Gray DW, Marshall I: Novel signal transduction pathway mediating endothelium-dependent-adrenoceptor vasorelaxation in rat thoracic aorta. Br J Pharmacol 1992; 107: 684-690.
5. Ferro A, Coash M, Yamamoto T, Rob J, Ji Y, Queen L: Nitric oxide-dependent,2-adrenergic dilatation of rat aorta is mediated through activation of both protein kinase A and Akt. Br J Pharmacol 2004; 143: 397-403. (Pubitemid 39424828)
6. Graves J, Poston L: Beta-adrenoceptor agonist mediated relaxation of rat isolated resistance arteries: a role for the endothelium and nitric oxide. Br J Pharmacol 1993; 108: 631-637. (Pubitemid 23067928)
7. Priest RM, Hucks D, Ward JPT: Noradrenaline adrenoceptor mediated vasorelaxation and nitric oxide in large and small pulmonary arteries of the rat. Br J Pharmacol 1997; 122: 1375-1384. (Pubitemid 27503928)
8. Pourageaud F, Leblais V, Bellance N, Marthan R, Muller B: Role of,2-adrenoceptors (AR), but not,1-,3-AR and endothelial nitric oxide, in AR-mediated relaxation of rat intrapulmonary artery. Naunyn Schmiedebergs Arch Pharmacol 2005; 372: 14-23.
9. Akimoto Y, Horinouchi T, Shibano M, Matsushita M, Yamashita Y, Okamoto T, Yamaki F, Tanaka Y, Koike K: Nitric oxide (NO) primarily accounts for endothelium-dependent component of adrenoceptor-activated smooth muscle relaxation of mouse aorta in response to isoprenaline. J Smooth Muscle Res 2002; 38: 87-99. (Pubitemid 36205760)
10. Leblais V, Delannoy E, Fresquet F, Bégueret H, Bellance N, Banquet S, Allieres C, Leroux L, Desgranges C, Gadeau A, Muller B: Adrenergic relaxation in pulmonary arteries: preservation of the endothelial nitric oxidedependent, 2 component in pulmonary hypertension. Cardiovasc Res 2008; 77: 202-210. (Pubitemid 351195141)
11. Dawes M, Chowienczyk PJ, Ritter JM: Effects of inhibition of the L-arginine/nitric oxide pathway on vasodilation caused by-adrenergic agonists in human forearm. Circulation 1997; 95: 2293-2297. (Pubitemid 27191007)
12. Chruscinski A, Brede ME, Meinel L, Lohse MJ, Kobilka BK, Hein L: Differential distribution of adrenergic receptor subtypes in blood vessels of knockout mice lacking, 1-or,2-adrenergic receptors. Mol Pharmacol 2001; 60: 955-962. (Pubitemid 33027430)
13. Rascado RR, Bendhack LM: Activation of,2-adrenoceptors is necessary to induce nitric oxide release in isoprenaline-induced relaxation. Vascul Pharmacol 2005; 42: 63-68. (Pubitemid 40250181)
14. Alexander SPH, Mathie A, Peters JA: Guide to Receptors and Channels (GRAC), 4th edition. Br J Pharmacol 2009; 158:S1-S254.
15. Ferro A, Queen LR, Priest RM, Xu B, Ritter JM, Poston L, Ward JP: Activation of nitric oxide synthase by, 2-adrenoceptors in human umbilical vein endothelium in vitro. Br J Pharmacol 1999; 126: 1872-1880. (Pubitemid 29213107)
16. Queen LR, Ji Y, Xu B, Young L, Yao K, Wyatt AW, Rowlands DJ, Siow RC, Mann GE, Ferro A: Mechanisms underlying, 2-adrenoceptor-mediated nitric oxide generation by human umbilical vein endothelial cells. J Physiol 2006; 576: 585-594. (Pubitemid 44490147)
17. Gillissen A, Wickenburg D, van Zwoll D, Schultze-Werninghaus G: Beta-2-agonists have antioxidant function in vitro. II. The effect of beta-2-agonists on oxidant-mediated cytotoxicity and on superoxide anion generated by human polymorphonuclear leukocytes. Respiration 1997; 64: 23-28. (Pubitemid 27055451)
18. Mirza ZN, Kato M, Kimura H, Tachibana A, Fujiu T, Suzuki M, Mochizuki H, Tokuyama K, Morikawa A: Fenoterol inhibits superoxide anion generation by human polymorphonuclear leukocytes via beta-adrenoceptor-dependent and-independent mechanisms. Ann Allergy Asthma Immunol 2002; 88: 494-500. (Pubitemid 36182008)
19. Trombetta IC, Batalha LT, Rondon MU, Laterza MC, Frazzatto E, Alves MJ, Santos AC, Brum PC, Barretto AC, Halpern A, Villares SM, Negrao CE: Gly16 + Glu27, 2-adrenoceptor polymorphisms cause increased forearm blood flow responses to mental stress and handgrip in humans. J Appl Physiol 2005; 98: 787-794. (Pubitemid 40283655)
20. Garovic VD, Joyner MJ, Dietz NM, Boerwinkle E, Turner ST: 2-Adrenergic receptor polymorphism and nitric oxide-dependent forearm blood flow responses to isoproterenol in humans. J Physiol 2003; 546: 583-589. (Pubitemid 36175993)
21. Chruscinski AJ, Rohrer DK, Schauble E, Desai KH, Bernstein D, Kobilka BK: Targeted disruption of the 2-adrenergic receptor gene. J Biol Chem 1999; 274: 16694-16700.
22. Rolim NP, Medeiros A, Rosa KT, Mattos KC, Irigoyen MC, Krieger EM, Krieger JE, Negrao CE, Brum PC: Exercise training improves the net balance of cardiac Ca 2+ handling protein expression in heart failure. Physiol Genomics 2007; 29: 246-252. (Pubitemid 47173296)
23. Rabelo LA, Cortes SF, Alvarez-Leite JI, Lemos VS: Endothelium dysfunction in LDL receptor knockout mice: a role for H 2 O 2. Br J Pharmacol 2003; 138: 1215-1220. (Pubitemid 36543118)
24. Davel AP, Kawamoto EM, Scavone C, Vassallo DV, Rossoni LV: Changes in vascular reactivity following administration of isoproterenol for 1 week: a role for endothelial modulation. Br J Pharmacol 2006; 148: 629-639. (Pubitemid 43993053)
25. Rossoni LV, Salaices M, Marín J, Vassallo DV, Alonso MJ : Alterations in phenylephrine-induced contractions and the vascular expression of Na +, K +-ATPase in ouabaininduced hypertension. Br J Pharmacol 2002; 135: 771-781. (Pubitemid 34177654)
26. Davel AP, Fukuda LE, Sá LL, Munhoz CD, Scavone C, Sanz-Rosa D, Cachofeiro V, Lahera V, Rossoni LV: Effects of isoproterenol treatment for 7 days on inflammatory mediators in the rat aorta. Am J Physiol Heart Circ Physiol 2008; 295: 211-219.
27. Iaccarino G, Ciccarelli M, Sorriento D, Galasso G, Campanile A, Santulli G, Cipolletta E, Cerullo V, Cimini V, Altobelli GG, Piscione F, Priante O, Pastore L, Chiariello M, Salvatore F, Koch WJ, Trimarco B: Ischemic neoangiogenesis enhanced by, 2-adrenergic receptor overexpression: a novel role for the endothelial adrenergic system. Circ Res 2005; 97: 1182-1189.
28. Van Hove CE, Van der Donckt C, Herman AG, Bult H, Fransen P: Vasodilator efficacy of nitric oxide depends on mechanisms of intracellular calcium mobilization in mouse aortic smooth muscle cells. Br J Pharmacol 2009; 158: 920-930.
29. Isenovi E, Walsh MF, Muniyappa R, Bard M, Diglio CA, Sowers JR: Phosphatidylinositol 3-kinase may mediate isoproterenol-induced vascular relaxation in part through nitric oxide production. Metabolism 2002; 51: 380-386. (Pubitemid 34232643)
30. Rohrer DK, Chruscinski A, Schauble EH, Bernstein D, Kobilka BK: Cardiovascular and metabolic alterations in mice lacking both beta1-and beta2-adrenergic receptors. J Biol Chem 1999; 274: 16701-16708.
31. Alvarez Y, Briones AM, Hernanz R, Pérez-Girón JV, Alonso MJ, Salaices M: Role of NADPH oxidase and iNOS in vasoconstrictor responses of vessels from hypertensive and normotensive rats. Br J Pharmacol 2008; 153: 926-935. (Pubitemid 351328931)
32. Giachini FR, Sullivan JC, Lima VV, Carneiro FS, Fortes ZB, Pollock DM, Carvalho MH, Webb RC, Tostes RC: Extracellular signalregulated kinase 1/2 activation, via downregulation of mitogen-activated protein kinase phosphatase 1, mediates sex differences in desoxycorticosterone acetate-salt hypertension vascular reactivity. Hypertension 2010; 55: 172-179.
33. Birukov KG: Cyclic stretch, reactive oxygen species, and vascular remodeling. Antioxid Redox Signal. 2009; 11: 1651-1667.
34. Duerrschmidt N, Stielow C, Muller G, Pagano PJ, Morawietz H: NO-mediated regulation of NAD(P)H oxidase by laminar shear stress in human endothelial cells. J Physiol 2006; 576: 557-567. (Pubitemid 44490145)
35. Selemidis S, Dusting GJ, Peshavariya H, Kemp-Harper BK, Drummond GR: Nitric oxide suppresses NADPH oxidase-dependent superoxide production by S-nitrosylation in human endothelial cells. Cardiovasc Res 2007; 75: 349-358. (Pubitemid 46961925)
36. Lassegue B, Griendling KK: NADPH oxidases: functions and pathologies in the vasculature. Arterioscler Thromb Vasc Biol 2010; 30: 653-661.
37. Ximenes VF, Kanegae MP, Rissato SR, Galhiane MS: The oxidation of apocynin catalyzed by myeloperoxidase: proposal for NADPH oxidase inhibition. Arch Biochem Biophys 2007; 457: 134-141. (Pubitemid 46048700)
38. Touyz RM: Apocynin, NADPH oxidase, and vascular cells: a complex matter. Hypertension 2008; 51: 172-174. (Pubitemid 351159922)
39. Burger D, Montezano AC, Nishigaki N, He Y, Carter A, Touyz RM: Endothelial microparticle formation by angiotensin II is mediated via Ang II receptor type I/NADPH oxidase/Rho kinase pathways targeted to lipid rafts. Arterioscler Thromb Vasc Biol 2011; 31: 1898-1907.
40. Barbieri SS, Cavalca V, Eligini S, Brambilla M, Caiani A, Tremoli E, Colli S: Apocynin prevents cyclooxygenase 2 expression in human monocytes through NADPH oxidase and glutathione redox-dependent mechanisms. Free Radic Biol Med 2004; 37: 156-165. (Pubitemid 38760252)
41. MacMillan-Crow LA, Cruthirds DL: Manganese superoxide dismutase in disease. Free Radical Res 2001; 34: 325-336.
42. Takahata Y, Takarada T, Iemata M, Yamamoto T, Nakamura Y, Kodama A, Yoneda Y: Functional expression of, 2-adrenergic receptors responsible for protection against oxidative stress through promotion of glutathione synthesis after Nrf2 upregulation in undifferentiated mesenchymal C3H10T1/2 stem cells. J Cell Physiol 2009; 218: 268-275.
43. Xu Q, Dalic A, Fang L, Kiriazis H, Ritchie RH, Sim K, Gao XM, Drummond G, Sarwar M, Zhang YY, Dart AM, Du XJ: Myocardial oxidative stress contributes to transgenic 2-adrenoceptor activation-induced cardiomyopathy and heart failure. Br J Pharmacol 2011; 162: 1012-1028.